Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28510591
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 PLoS+One
2017 ; 12
(5
): e0177108
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
The case for investing in the male condom
#MMPMID28510591
Stover J
; Rosen JE
; Carvalho MN
; Korenromp EL
; Friedman HS
; Cogan M
; Deperthes B
PLoS One
2017[]; 12
(5
): e0177108
PMID28510591
show ga
When used correctly and consistently, the male condom offers triple protection
from unintended pregnancy and the transmission of sexually transmitted infections
(STIs) and human immunodeficiency virus (HIV). However, with health funding
levels stagnant or falling, it is important to understand the cost and health
impact associated with prevention technologies. This study is one of the first to
attempt to quantify the cost and combined health impact of condom use, as a means
to prevent unwanted pregnancy and to prevent transmission of STIs including HIV.
This paper describes the analysis to make the case for investment in the male
condom, including the cost, impact and cost-effectiveness by three scenarios (low
in which 2015 condom use levels are maintained; medium in which condom use trends
are used to predict condom use from 2016-2030; and high in which condom use is
scaled up, as part of a package of contraceptives, to meet all unmet need for
family planning by 2030 and to 90% for HIV and STI prevention by 2016) for 81
countries from 2015-2030. An annual gap between current and desired use of 10.9
billion condoms was identified (4.6 billion for family planning and 6.3 billion
for HIV and STIs). Under a high scenario that completely reduces that gap between
current and desired use of 10.9 billion condoms, we found that by 2030 countries
could avert 240 million DALYs. The additional cost in the 81 countries through
2030 under the medium scenario is $1.9 billion, and $27.5 billion under the high
scenario. Through 2030, the cost-effectiveness ratios are $304 per DALY averted
for the medium and $115 per DALY averted for the high scenario. Under the three
scenarios described above, our analysis demonstrates the cost-effectiveness of
the male condom in preventing unintended pregnancy and HIV and STI new
infections. Policy makers should increase budgets for condom programming to
increase the health return on investment of scarce resources.
|*Condoms/economics
[MESH]
|Adolescent
[MESH]
|Adult
[MESH]
|Cost-Benefit Analysis
[MESH]
|Family Planning Services/economics
[MESH]
|Female
[MESH]
|Global Health
[MESH]
|HIV Infections/prevention & control
[MESH]
|Humans
[MESH]
|Male
[MESH]
|Middle Aged
[MESH]
|Pregnancy
[MESH]
|Pregnancy, Unplanned
[MESH]
|Sexually Transmitted Diseases/prevention & control
[MESH]
free
free
free
